BEI
DNA icon

Benjamin Edwards Inc’s Ginkgo Bioworks DNA Stock Holding History

Benjamin Edwards Inc’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43
Closed -$1K – 1112
2024
Q2 		$1K Sell
43
-187
-81% -$5.58K ﹤0.01% 678
2024
Q1 		$11K Buy
230
+58
+34% +$3K ﹤0.01% 635
2023
Q4 		$12K Sell
172
-62
-26% -$3.8K ﹤0.01% 575
2023
Q3 		$17K Buy
234
+42
+22% +$3.36K ﹤0.01% 539
2023
Q2 		$14K Buy
192
+44
+30% +$2.6K ﹤0.01% 548
2023
Q1 		$8K Buy
148
+38
+35% +$2.41K ﹤0.01% 594
2022
Q4 		$7K Buy
110
+31
+39% +$2.85K ﹤0.01% 613
2022
Q3 		$10K Sell
79
-1
-1% -$119 ﹤0.01% 558
2022
Q2 		$8K Buy
80
+28
+54% +$3.42K ﹤0.01% 598
2022
Q1 		$8K Buy
+52
New +$10.1K ﹤0.01% 619

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return